Skip to main content
Top
Published in: BMC Infectious Diseases 1/2022

Open Access 01-12-2022 | Human Immunodeficiency Virus | Research article

The effect of homelessness on viral suppression in an underserved metropolitan area of middle Tennessee: potential implications for ending the HIV epidemic

Authors: Vladimir Berthaud, Livette Johnson, Ronda Jennings, Maxine Chandler-Auguste, Abosede Osijo, Marie T. Baldwin, Patricia Matthews-Juarez, Paul Juarez, Derek Wilus, Mohammad Tabatabai

Published in: BMC Infectious Diseases | Issue 1/2022

Login to get access

Abstract

Background

A wealth of scientific evidence supports the effectiveness of HIV prophylaxis and treatment. Homelessness is strongly associated with the health status and viral suppression among underserved populations and can undermine the national plan to eliminate HIV by 2030. This retrospective observational study examined the extent in which homelessness affects HIV treatment in an underserved urban area of Middle Tennessee in 2014–2019.

Results

Among 692 HIV-seropositive patients, the proportion of homeless patients increased from 13.5% in 2014 to 27.7% in 2019, thrice the national average for HIV-seropositive people (8.4%) and twice that of HIV positive patients who are participating in Ryan White programs nationwide (12.9%). Our findings suggest that homeless patients were half as likely to achieve viral suppression as compared to those who had a permanent/stable home [OR 0.48 (0.32–0.72), p-value < 0.001].

Conclusion

Our study indicates that homelessness may play an important role in viral suppression among persons living with HIV/AIDS in Middle Tennessee.
Literature
1.
go back to reference Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2014–2018. HIV Surveillance Report, Supplemental Report, volume 24, Number 1. Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2014–2018. HIV Surveillance Report, Supplemental Report, volume 24, Number 1.
3.
go back to reference Milloy M-J, Marshall BDL, Montaner J, Wood E. Housing status and the health of people living with HIV/AIDS. Curr HIV/AIDS Rep. 2012;9(4):364–74.CrossRef Milloy M-J, Marshall BDL, Montaner J, Wood E. Housing status and the health of people living with HIV/AIDS. Curr HIV/AIDS Rep. 2012;9(4):364–74.CrossRef
4.
go back to reference Craig T. Homeless deaths surge. The Washington Post, 2018. Craig T. Homeless deaths surge. The Washington Post, 2018.
5.
go back to reference Muthulingam D, Chin J, Hsu L, et al. Disparities in engagement in care and viral suppression among persons with HIV. J Acquir Immune Defic Syndr. 2013;63:112–9.CrossRef Muthulingam D, Chin J, Hsu L, et al. Disparities in engagement in care and viral suppression among persons with HIV. J Acquir Immune Defic Syndr. 2013;63:112–9.CrossRef
6.
go back to reference Thakarar K, Morgan JR, Gaeta JM, et al. Homelessness, HIV, and incomplete viral suppression. J Health Care Poor Underserved. 2016;27(1):145–56.CrossRef Thakarar K, Morgan JR, Gaeta JM, et al. Homelessness, HIV, and incomplete viral suppression. J Health Care Poor Underserved. 2016;27(1):145–56.CrossRef
7.
go back to reference Loh J, Kennedy MC, Wood E, et al. Longer duration of homelessness is associated with a lower likelihood of non-detectable plasma HIV-1 RNA viral load among people who use illicit drugs in a Canadian setting. AIDS Care. 2016;28(11):1448–54.CrossRef Loh J, Kennedy MC, Wood E, et al. Longer duration of homelessness is associated with a lower likelihood of non-detectable plasma HIV-1 RNA viral load among people who use illicit drugs in a Canadian setting. AIDS Care. 2016;28(11):1448–54.CrossRef
8.
go back to reference Clemenzi-Allen A, Geng E, Christopoulos K, et al. Degree of housing instability shows independent “dose-response” with virologic suppression rates among people living with human immunodeficiency virus. Open Forum Infect Dis. 2018;5:1–3.CrossRef Clemenzi-Allen A, Geng E, Christopoulos K, et al. Degree of housing instability shows independent “dose-response” with virologic suppression rates among people living with human immunodeficiency virus. Open Forum Infect Dis. 2018;5:1–3.CrossRef
9.
go back to reference Kidder DP, Wolitski RJ, Campsmith ML, et al. Health status, health care use, medication use, and medication adherence among homeless and housed people living with HIV/AIDS. Am J Public Health. 2007;97(12):2238–45.CrossRef Kidder DP, Wolitski RJ, Campsmith ML, et al. Health status, health care use, medication use, and medication adherence among homeless and housed people living with HIV/AIDS. Am J Public Health. 2007;97(12):2238–45.CrossRef
11.
go back to reference Bowen EA, Canfield J, Moore S, et al. Predictors of CD4 health and viral suppression outcomes for formerly homeless people living with HIV/AIDS in scattered site supportive housing. AIDS Care. 2017;29(11):1458–62.CrossRef Bowen EA, Canfield J, Moore S, et al. Predictors of CD4 health and viral suppression outcomes for formerly homeless people living with HIV/AIDS in scattered site supportive housing. AIDS Care. 2017;29(11):1458–62.CrossRef
12.
go back to reference Nasrullah M, Frazier EL, Fagan J, et al. The association of recent incarceration and health outcomes among HIV-infected adults receiving care in the United States. Int J Prison Health. 2016;12(3):135–44.CrossRef Nasrullah M, Frazier EL, Fagan J, et al. The association of recent incarceration and health outcomes among HIV-infected adults receiving care in the United States. Int J Prison Health. 2016;12(3):135–44.CrossRef
13.
go back to reference Lim S, Nash D, Hollod L, et al. Influence of jail incarceration and homelessness patterns on engagement in HIV care and HIV viral suppression among New York City adults living with HIV/AIDS. PLoS ONE. 2015;10:1–12. Lim S, Nash D, Hollod L, et al. Influence of jail incarceration and homelessness patterns on engagement in HIV care and HIV viral suppression among New York City adults living with HIV/AIDS. PLoS ONE. 2015;10:1–12.
14.
go back to reference Adams L, Nicholas T. Work and opportunity before and after incarceration. The Brookings Institution, 2018. Adams L, Nicholas T. Work and opportunity before and after incarceration. The Brookings Institution, 2018.
15.
go back to reference Bhunu CP. Assessing the impact of homelessness on HIV/AIDS transmission dynamics. Cogent Math. 2015;2:2–13.CrossRef Bhunu CP. Assessing the impact of homelessness on HIV/AIDS transmission dynamics. Cogent Math. 2015;2:2–13.CrossRef
16.
go back to reference Weiser SD, Frongillo EA, Ragland K, et al. Food insecurity is associated with incomplete HIV RNA suppression among homeless and marginally housed HIV-infected individuals in San Francisco. I Gen Intern Med. 2008;24:14–20.CrossRef Weiser SD, Frongillo EA, Ragland K, et al. Food insecurity is associated with incomplete HIV RNA suppression among homeless and marginally housed HIV-infected individuals in San Francisco. I Gen Intern Med. 2008;24:14–20.CrossRef
17.
go back to reference Riley ED, Neilands TB, Moore K, et al. Social, structural and behavioral determinants of overall health status in a cohort of homeless and unstably housed HIV-infected men. PLoS ONE. 2012;7(4):1–7.CrossRef Riley ED, Neilands TB, Moore K, et al. Social, structural and behavioral determinants of overall health status in a cohort of homeless and unstably housed HIV-infected men. PLoS ONE. 2012;7(4):1–7.CrossRef
Metadata
Title
The effect of homelessness on viral suppression in an underserved metropolitan area of middle Tennessee: potential implications for ending the HIV epidemic
Authors
Vladimir Berthaud
Livette Johnson
Ronda Jennings
Maxine Chandler-Auguste
Abosede Osijo
Marie T. Baldwin
Patricia Matthews-Juarez
Paul Juarez
Derek Wilus
Mohammad Tabatabai
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2022
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-022-07105-y

Other articles of this Issue 1/2022

BMC Infectious Diseases 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine